ADRs in Focus: Shire Falls on Downgrade - Conde Nast Portfolio
Conde Nast Portfolio, NY - Jan 30, 2008
Dani Saurymper downgraded the stock to "Neutral" from "Buy," and said that doctors do not find Vyvanse to be superior to Adderall XR, Shire's older ADHD …
Find Out More:
Books:
February 3rd, 2008
Vyvanse
Leave a Reply